Editorial
doi: 10.3390/pharmaceutics12050418.
Nanoparticles to Improve the Efficacy of Vaccines
Affiliations
- PMID: 32370192
- PMCID: PMC7284527
- DOI: 10.3390/pharmaceutics12050418
Item in Clipboard
Editorial
Nanoparticles to Improve the Efficacy of Vaccines
Pharmaceutics.
.
Abstract
This editorial aims to summarize the nine scientific papers that contributed to the Special Issue entitled 'Nanoparticles to Improve the Efficacy of Vaccines'.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Editorial of Special Issue "Differential Diagnosis for Dry Eye".Diagnostics (Basel). 2021 May 20;11(5):910. doi: 10.3390/diagnostics11050910. Diagnostics (Basel). 2021. PMID: 34065167 Free PMC article.
-
Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".Int J Mol Sci. 2019 Dec 17;20(24):6352. doi: 10.3390/ijms20246352. Int J Mol Sci. 2019. PMID: 31861113 Free PMC article.
-
Special Issue on Basic and Translational Research in Colorectal Cancer.Int J Mol Sci. 2019 Jun 25;20(12):3095. doi: 10.3390/ijms20123095. Int J Mol Sci. 2019. PMID: 31242580 Free PMC article.
-
Utilizing gnotobiotic models to inform the role of the microbiome in vaccine response heterogeneity.Curr Opin HIV AIDS. 2018 Jan;13(1):1-8. doi: 10.1097/COH.0000000000000422. Curr Opin HIV AIDS. 2018. PMID: 29176431 Review.
-
Systems Biology Approach for Cancer Vaccine Development and Evaluation.Vaccines (Basel). 2015 Jul 14;3(3):544-55. doi: 10.3390/vaccines3030544. Vaccines (Basel). 2015. PMID: 26350594 Free PMC article. Review.
Cited by
-
Current status of nano-vaccinology in veterinary medicine science.Vet Med Sci. 2023 Sep;9(5):2294-2308. doi: 10.1002/vms3.1221. Epub 2023 Jul 24. Vet Med Sci. 2023. PMID: 37487030 Free PMC article. Review.
-
Recent Advances and Future Perspectives in Polymer-Based Nanovaccines.Vaccines (Basel). 2021 May 26;9(6):558. doi: 10.3390/vaccines9060558. Vaccines (Basel). 2021. PMID: 34073648 Free PMC article. Review.
-
Structural Alterations of Antigens at the Material Interface: An Early Decision Toolbox Facilitating Safe-by-Design Nanovaccine Development.Int J Mol Sci. 2021 Oct 8;22(19):10895. doi: 10.3390/ijms221910895. Int J Mol Sci. 2021. PMID: 34639235 Free PMC article.
-
Immunogenicity of trivalent DNA vaccine candidate encapsulated in Chitosan-TPP nanoparticles against EV-A71 and CV-A16.Nanomedicine (Lond). 2024;19(21-22):1779-1799. doi: 10.1080/17435889.2024.2372243. Epub 2024 Aug 14. Nanomedicine (Lond). 2024. PMID: 39140594 Free PMC article.
References
-
- World Health Organization, Global Vaccine Action Plan 2011–2020. [(accessed on 1 May 2020)]; Available online: https://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_201...
-
- Kye Y.C., Park S.M., Shim B.S., Firdous J., Kim G., Kim H.W., Ju Y.J., Kim C.G., Cho C.S., Kim D.W., et al. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection. Acta Biomater. 2019;9:362–372. doi: 10.1016/j.actbio.2019.03.049. - DOI - PubMed
-
- Kang H.J., Lee S.H., Kim M.J., Chu K.B., Lee D.H., Chopra M., Choi H.J., Park H., Jin H., Quan F.S. Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection. Pharmaceutics. 2019;11:342. doi: 10.3390/pharmaceutics11070342. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
